An interventional study of Caffeine and Placebo in Caffeine, Affect and Goals, sponsored by Jagiellonian University. Recruiting at 1 site in Poland. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-20.
Sponsored by Jagiellonian University · Not applicable, Interventional, and Basic science
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies testing caffeine in Motor Activity — 2 open to participants now, 2 under way, none of them phase 3. Caffeine · Motor Activity.
Among the 13 studies testing caffeine in Motor Activity, this one is the 3rd largest by planned enrollment, is one of 2 that started in 2024, is one of 11 with no phase, and was the 7th registered.
9,827 studies on the registry are indexed under Motor Activity; 1,911 are open to participants now.
Browse Motor Activity studies →2 of the 13 studies testing caffeine in Motor Activity are open now, in 2 countries. Recruiting first, the newest first:
Universidad Rey Juan Carlos · Sites in Spain
Ages 18–50 · Healthy volunteers
By country, each count listing its studies:
Caffeine: first FDA approval 1948 (CAFERGOT), first EMA approval 2009. What it is approved for, and how studies give it, is on its page →
Of the 1,207 Motor Activity studies recruiting now, 524 (43%) set no upper age limit and 538 (45%) stop at 75 or younger; 180 take children under 18; 420 take healthy volunteers.
This study: 18 Years to 30 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2010; this study’s year is marked. 2 started in 2024.
This study's planned enrollment of 40 is below the median of 60 across 8,412 interventional studies indexed under Motor Activity.
Median enrollment 23 across the 13 interventional studies. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 13 has an industry lead sponsor. The 10 most frequent:
Jagiellonian University is the lead sponsor of 161 studies on the registry; 34 are open to participants now.
Jagiellonian University has 1 study filed under Motor Activity — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 13 studies testing caffeine in Motor Activity, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The main objective of the study is to evaluate the influence of caffeine intake on participants' energetic arousal, affect, motivation to achieve a training goal, satisfaction with training, and the sense of agency during training. Consequently, participants will engage in three sessions: caffeine, placebo, and no substance (in counterbalanced order). During each session, their affective and motivational states will be assessed, along with the performance of a standardized physical exercise test. The investigators hypothesize that participants who consume caffeine (caffeine condition) will exhibit higher levels of energy and motivation compared to the other two groups. Additionally, they are expected to experience greater optimism and expectancy regarding their training goals and achieve better results in the physical exercise test.
A secondary aim of the study is to examine the impact of genetic variability on motivational and affective states of participants, as well as their performance in the physical exercise test after caffeine. The investigators will assess the CYP1A2 (-163C > A, rs762551; characterized such as "fast" (AA genotype) and "slow" caffeine metabolizers (C-carriers)) and ADORA2A (1976T > C; rs5751876; characterized by "high" (TT genotype) or "low" sensitivity to caffeine (C-carriers)).
Before participating in the study, participants will answer questions regarding their consumption of caffeinated beverages and the frequency of their workouts. They will also complete the Extreme Personality Scale measuring the tendency to pursue goals single-mindedly. Subsequently, they will be qualified for the study based on the questionnaire results and a brief interview.
The study will involve the manipulation of energization through the administration of caffeine. Participants will take part in a randomized, crossover, double-blind study, where they will perform three identical training sessions after consuming: a) caffeine at a dose of 3 mg/kg of body weight; b) a placebo; and c) under control conditions (i.e., without substance administration). Capsule consumption will occur 60 minutes before the start of the training. Caffeine and placebo capsules will not differ in size, shape, color, and taste.
As the effectiveness of caffeine use depends on the CYP1A2 (rs762551) and ADORA2 (rs5751876) gene polymorphisms, the study will also genotype these genes. The first gene is responsible for the rate of caffeine metabolism, determining whether people metabolize caffeine "fast" or "slow." The ADORA2A gene, encoding the adenosine A2A receptor, influences how "sensitive" people are to caffeine. DNA isolates obtained from oral epithelial cells collected from participants by qualified medical personnel will constitute the research material. Oral epithelial swabs will be collected directly from the participants into sterile tubes.
Before and after substance intake (and additionally after the exercise test) participants will assess their arousal using the University of Wales Institute of Science and Technology Mood Adjective Checklist. Additionally, after substance intake and before exercise, participants will answer questions about motivation, affect and expectancy regarding training. Subsequently, participants will undergo training, taking the form of a supervised standardized exercise test. After exercise, participants will assess their satisfaction and feelings after completing the training.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participation in the study will be preceded by completing a health questionnaire and providing written consent. Additionally, exclusion from the study will occur upon the explicit request of the participant.
Participants will take a caffeine pill (3mg/kg of body mass) 60 minutes before the physical exercise test.
Dietary Supplement: Caffeine
Participants will take a placebo pill 60 minutes before the physical exercise test.
Dietary Supplement: Placebo
Participants receive no pills in this condition before the physical exercise test.
Other: No substance
Participants will take one caffeine pill. The dose of caffeine will be calculated based on participants' body mass (3mg/kg body mass). Caffeine will be provided in capsules containing the individual amount of caffeine and will be administered orally 60 min before the onset of the exercise protocol.
Participants will take one pill with no caffeine in it. The manufacturer of the caffeine capsules will also prepare identical placebo capsules filled out with a microcrystalline cellulose. Placebo will be administered orally 60 min before the onset of the exercise protocol.
Participants will take no substance. They will just wait 60 minutes and then engage in the exercise protocol.
Energetic arousal pre-test
Self-reported energetic arousal contrasting vigour with fatigue, measured with the energetic arousal sub-scale of the University of Wales Institute of Science and Technology Mood Adjective Checklist. The values range from 1-4; higher scores indicate greater energetic arousal.
Time frame: Right before the intervention
Energetic arousal post-test
Self-reported energetic arousal measured with the energetic arousal sub-scale of the University of Wales Institute of Science and Technology Mood Adjective Checklist. The values range from 1-4; higher scores indicate greater energetic arousal. The change relative to the pre-test will be analyzed.
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Optimism
Situational optimism (expectancy of positive outcomes) measured with 4 items were participants rate the extent to which they: 1) are positively oriented. 2) are full of optimism. 3) can achieve what I set out to do. 4) are capable of a lot. Responses are given on a 1-7 Likert scale. Higher scores indicate greater optimism. The mean of these items will be computed and the change relative to the pre-test will be analyzed.
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Motivation
Motivation to accomplish one's training goals measured with a question where participants rate the extent to which they are motivated to achieve the best result in: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond to each item on a 1-7 Likert scale. Higher scores indicate greater motivation.
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Determination
Determination to accomplish one's training goals measured with 4 items: 1) During training, everything else will become irrelevant for \[the participant\[. 2) \[The participant\] will put a lot of energy into the training. 3) \[The participant\] will do everything in their power to achieve the training goal. 4) \[The participant\] will reach the training goal even if it requires a great effort. 5) \[The participant\] will train despite fatigue. Participants respond to each item on a 1-7 Likert scale. Higher scores indicate greater determination.
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Relative outcome expectancy
Expectancy of the training results measured with a question: In relation to participants' typical result, what result do they expect in: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond to each item on a 1-7 scale anchored 1 = definitely worse than usual and 7 = definitely better than usual. Higher scores indicate more positive outcome expectations.
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Success probability
Subjective probability of attaining the best result measured with a question: How likely do participants think it is that they will achieve the best result in: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond to each item on a 1-7 scale anchored 1 = completely unlikely and 7 = certain. Higher scores indicate greater probability of success.
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Prospective effort
Participants' willingness to invest effort in the training measured with a question: How much effort are participants planning to invest in: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond on a 0-100% scale. Higher scores indicate greater willingness to invest effort.
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Agency
Sense of agency measured with two questions: 1) Do participants feel in control over the outcome in..., 2) Do participants feel in control over their performance in... Participants respond to each question in relation to each test outcome: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Responses are given on 1-6 scale anchored 1 = no control and 7 = complete control. Higher scores indicate greater sense of agency.
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Performance in the 1RM test
Participants' performance in the one-repetition maximum test in bench press \[number of kg\]
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition)
Performance in the bar velocity in the bench press test
Participants' performance in the bar velocity during 3 sets of 3 repetitions in the bench press exercise \[m/s\]
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition)
Performance in the strength-endurance test
Participants' performance in the strength-endurance test in bench press test (number of repetitions)
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition)
Performance in the countermovement jump test
Participants' performance in the countermovement jump test (number of cm)
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition)
Satisfaction with the results
Participants' satisfaction with their training results measured with a question: How satisfied are participants with their results in: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond to each item on a 1-7 scale anchored 1 = definitely unsatisfied to 7 = definitely satisfied. Higher scores indicate greater satisfaction with the results.
Time frame: Immediately after the physical exercise test
Retrospective effort
Participants' assessment of effort invested in the training measured with a question: How much effort did participants invest in:1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond on a 0-100% scale. Higher scores indicate greater effort.
Time frame: Immediately after the physical exercise test
Retrospective agency
Sense of agency measured with two questions: 1) Did participants feel in control over the outcome in..., 2) Did participants feel in control over their performance in... Participants respond to each question in relation to each test outcome: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Responses are given on 1-6 scale anchored 1 = no control and 7 = complete control. Higher scores indicate greater sense of agency.
Time frame: Immediately after the physical exercise test
Goal importance
Importance of the training goal measured with a question: How important is it for participants to achieve the best possible result in: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond to each item on a 1-7 scale anchored 1 = completely unimportant and 7 = extremely important. Higher scores indicate greater importance.
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Prospective difficulty
Perceived difficulty of the training goal measured with a question: How do participants assess the difficulty of: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants respond to each item on a 1-7 scale anchored 1 = definitely easy and 7 = definitely difficult. Higher scores indicate greater subjective difficulty.
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Expected performance in the 1RM test
Participants' expected performance in the 1 RM test. Participants provide responses to the following questions: How much weight do participants think they will lift in the 1 RM test? (participants provide in kg)
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Expected performance in the bar velocity in the bench press test
Participants' expected performance in the bar velocity in the bench press test. Participants provide a response to the following question: How much m/s. do participants expect to achieve in the bar velocity test? (participants provide the response in m/s)
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Expected performance in the strength-endurance test
Participants' expected performance in the strength-endurance test. Participants provide a response to the following question: How many repetitions do participants think they will perform in the strength-endurance test? (participants provide the number of repetitions)
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Expected performance in the countermovement jump test
Participants' expected performance in the countermovement jump test. Participants provide a response to the following question: How high do participants think they will jump? (participants provide in cm)
Time frame: 60 minutes after taking the capsule (waiting in the no-intervention condition); before training
Retrospective difficulty
Assessed difficulty of each training element: 1) one-repetition maximum bench press test, 2) bar velocity in the bench press test, 3) strength-endurance test, 4) countermovement jump. Participants rate each element twice (generally and in relation to their other trainings) on a 1-7 scale anchored 1 = very easy and 7 = very difficult. Higher scores indicate greater difficulty.
Time frame: Immediately after the physical exercise test
Energetic arousal post-training
Self-reported energetic arousal measured with the energetic arousal sub-scale of the University of Wales Institute of Science and Technology Mood Adjective Checklist. The values range from 1-4; higher scores indicate greater energetic arousal.
Time frame: Immediately after the physical exercise test
Perceived effect on agency
Assessed effect on the sense of agency measured with an item: To what extent do participants agree with the statement: Completing this workout made participants feel like they had control. Participants respond on 1-7 Likert scale. Higher scores indicate the greater perceived effect on agency.
Time frame: Immediately after the physical exercise test
Tense arousal
Self-reported tense arousal contrasting tension with relaxation, measured with the Tense Arousal subscale of the University of Wales Institute of Science and Technology Mood Adjective Checklist. The values range from 1-4; higher scores indicate greater energetic arousal.
Time frame: Right before the intervention, then 60 minutes after taking the capsule (waiting in the no-intervention condition); and immediately after the physical exercise test
Hedonic tone
Self-reported hedonic tone contrasting pleasant with unpleasant moods, measured with the Hedonic Tone subscale of the University of Wales Institute of Science and Technology Mood Adjective Checklist. The values range from 1-4; higher scores indicate greater energetic arousal.
Time frame: Right before the intervention, then 60 minutes after taking the capsule (waiting in the no-intervention condition); and immediately after the physical exercise test
Plan to share: Yes — Anonymized IPD will be shared digitally via the Jagiellonian University Repository.
Supporting information: Study protocol, Informed consent form, Analytic code
Time frame: The data will become available after preparing the article summarizing the study results. The data will be shared for at least 5 years.
Access criteria: All researchers possessing the link to the data will be able to access it.
Started Jan 2024 (actual). Primary completion is estimated for May 2024, 3 months after the start.
Of 5,176 non-industry interventional studies with no phase under Motor Activity, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 3 months is below that.
Counting every sponsor, half of 5,236 studies reached it within 17 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Caffeine